發(fā)布時(shí)間：2018-10-25 19:51

【摘要】：目的:研究脈血康膠囊對(duì)急性腦梗死患者術(shù)后凝血功能、血管內(nèi)皮損傷及血清炎性相關(guān)因子的影響。方法:選取2012年7月至2016年2月于本院行選擇性動(dòng)脈溶栓術(shù)的119例急性腦梗死患者作為研究對(duì)象,按隨機(jī)數(shù)字表法分為觀察組58例和對(duì)照組61例,對(duì)照組給予常規(guī)治療,觀察組在對(duì)照組治療基礎(chǔ)上口服脈血康膠囊,2組治療3個(gè)月分別檢測(cè)治療前后凝血功能指標(biāo)、血管內(nèi)皮損傷指標(biāo)及血清炎性因子水平。結(jié)果:觀察組總有效率(91.80%)顯著高于對(duì)照組(70.69%)。治療前,2組患者的凝血功能和指標(biāo)(PT、TT、APTT、FIB)、血管內(nèi)皮損傷(ET-1、TXB_2、NO)及血清炎性因子(IL-6、TNF-α、CRP)水平比較差異有統(tǒng)計(jì)學(xué)意義。治療后,觀察組的PT、TT、APTT與治療前比較均顯著升高,而FIB較治療前無(wú)顯著性變化,其中觀察組的PT、TT均顯著高于同期的對(duì)照組,對(duì)照組的PT、TT、APTT和FIB較治療前無(wú)顯著性變化,觀察組的ET-1和TXB_2較治療前顯著降低,NO較治療前升高且顯著高于同期對(duì)照組。對(duì)照組的ET-1、TXB_2、NO較治療前無(wú)顯著性變化。,觀察組的IL-6、TNF-α、CRP較治療前顯著減低且分別顯著低于對(duì)照組,對(duì)照組IL-6、TNF-α較治療前顯著降低。結(jié)論:脈血康膠囊對(duì)腦梗死患者起到良好的療效,可有效恢復(fù)患者術(shù)后凝血功能、血管內(nèi)皮損傷,有效降低血清炎性因子水平,可作為急性腦梗死患者術(shù)后的輔助治療。
[Abstract]:Aim: to study the effects of Mai Xue Kang capsule on coagulation function, vascular endothelial injury and serum inflammatory related factors in patients with acute cerebral infarction. Methods: 119 patients with acute cerebral infarction who underwent selective thrombolytic thrombolysis from July 2012 to February 2016 were divided into observation group (n = 58) and control group (n = 61). The observation group was treated with Mai Xue Kang capsule on the basis of the control group, and the coagulation function index, vascular endothelial injury index and serum inflammatory factor level were measured before and after treatment for 3 months in the two groups. Results: the total effective rate of the observation group (91.80%) was significantly higher than that of the control group (70.69%). Before treatment, there were significant differences in coagulation function and index (PT,TT,APTT,FIB), vascular endothelial injury (ET-1,TXB_2,NO) and serum inflammatory factor (IL-6,TNF- 偽, CRP) between the two groups. After treatment, the PT,TT,APTT of the observation group was significantly higher than that of the control group, but the FIB had no significant change. The PT,TT of the observation group was significantly higher than that of the control group, and the PT,TT, of the control group was significantly higher than that of the control group. There was no significant change in APTT and FIB. The ET-1 and TXB_2 in the observation group were significantly lower than those before the treatment, and the NO was higher and higher than that in the control group. The IL-6,TNF- 偽 and CRP of the observation group were significantly lower than that of the control group, and the IL-6,TNF- 偽 of the control group was significantly lower than that of the control group. Conclusion: Maixuekang capsule has a good curative effect on patients with cerebral infarction, it can effectively restore the blood coagulation function, vascular endothelial injury, reduce the level of serum inflammatory factors, and can be used as an adjuvant treatment for patients with acute cerebral infarction after operation.
【作者單位】： 無(wú)錫市中西醫(yī)結(jié)合醫(yī)院神經(jīng)內(nèi)科;
【分類(lèi)號(hào)】：R277.7

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 鄧智武;宋盛青;黃健虹;麥艷薇;;脈血康膠囊治療椎-基底動(dòng)脈缺血性眩暈療效觀察[J];河北中醫(yī);2006年03期

2 李雁;王韶兵;;脈血康膠囊對(duì)冠心病患者心率變異的干預(yù)作用[J];黑龍江中醫(yī)藥;2006年03期

3 魏玲玲;李秋貴;;脈血康膠囊治療糖尿病性周?chē)窠?jīng)病變的臨床觀察[J];中華中醫(yī)藥雜志;2008年05期

4 阮海娃;暢亦杰;;脈血康膠囊治療急性腦梗死112例臨床療效觀察[J];中國(guó)中藥雜志;2011年05期

5 陳奎;盧燕;;脈血康膠囊治療急性腦梗死療效觀察[J];中國(guó)現(xiàn)代藥物應(yīng)用;2012年18期

6 胡磊;;脈血康膠囊治療腎內(nèi)科疾病舉隅[J];中國(guó)現(xiàn)代藥物應(yīng)用;2013年04期

7 商廣蕓;王宏宇;劉金波;付曉葆;;脈血康膠囊治療下肢動(dòng)脈硬化閉塞癥60例療效觀察[J];中外醫(yī)療;2013年07期

8 葛長(zhǎng)江;苑飛;馮利霞;呂樹(shù)錚;柳弘;宋現(xiàn)濤;陳欣;霍勇;;Clinical Effect of Maixuekang Capsule(脈血康膠囊) on LongTerm Prognosis in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention[J];Chinese Journal of Integrative Medicine;2014年02期

9 王昕冉;;脈血康膠囊配燈盞細(xì)辛及外敷祛腐生肌膏治療血栓閉塞性脈管炎[J];陜西中醫(yī);2007年02期

10 張彪;;脈血康膠囊治療下肢深靜脈血栓52例臨床觀察[J];實(shí)用心腦肺血管病雜志;2008年09期

相關(guān)會(huì)議論文 前5條

1 商廣蕓;王宏宇;劉金波;付曉葆;;脈血康膠囊治療下肢動(dòng)脈硬化閉塞癥60例療效觀察[A];中華醫(yī)學(xué)會(huì)第十五次全國(guó)心血管病學(xué)大會(huì)論文匯編[C];2013年

2 賀志偉;王湘富;楊翰文;謝興澤;魯邦福;彭描宇;謝慶成;;脈血康膠囊對(duì)經(jīng)皮冠狀動(dòng)脈介入患者長(zhǎng)期預(yù)后的影響[A];2010全國(guó)中西醫(yī)結(jié)合危重病、急救醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2010年

3 賀志偉;楊翰文;彭描宇;劉美榮;何銀輝;;脈血康膠囊對(duì)經(jīng)皮冠狀動(dòng)脈介入患者長(zhǎng)期預(yù)后的影響[A];第十次中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)心血管病學(xué)術(shù)大會(huì)暨第五次江西省中西醫(yī)結(jié)合學(xué)會(huì)心血管病學(xué)術(shù)大會(huì)論文匯編[C];2010年

4 張凱亮;;腸溶脈血康膠囊治療突聾療效分析[A];世界中聯(lián)耳鼻喉口腔專(zhuān)業(yè)委員會(huì)換屆大會(huì)及第三次學(xué)術(shù)年會(huì)暨中華中醫(yī)藥學(xué)會(huì)耳鼻喉科分會(huì)第十七次學(xué)術(shù)交流會(huì)暨廣東省中醫(yī)及中西醫(yī)結(jié)合學(xué)會(huì)耳鼻喉科學(xué)術(shù)交流會(huì)論文匯編[C];2011年

5 吳青;吳一品;;脈血康膠囊配燈盞細(xì)辛及外敷祛腐生肌膏治療血栓閉塞性脈管炎[A];第十四次全國(guó)中西醫(yī)結(jié)合瘍科學(xué)術(shù)交流會(huì)論文匯編[C];2009年

，

本文編號(hào)：2294664